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Introduction
Endogenous estrogen depletion is believed to contribute to several health problems through women's life. Several epidemiological studies suggested that the postmenopausal state is involved with the development of some gender-specific diseases such as osteoarthritis and lumbar degenerative spondylolisthesis 1, 2 . These diseases are attributed to cartilage damage in the knee joint, the vertebral endplate, and the intervertebral disc of the lumbar spine.
The epidemiological gap of the incidence of diseases between females and males continues to increase with aging 3 . Although the presence of estrogen receptors (ERs) in chondrocytes raises a possibility that cartilaginous tissues are estrogen-sensitive, the precise mechanism of cartilage homeostasis by estrogen is not fully understood 4 .
Estrogen, especially 17b-estradiol (E 2 ) has versatile effects on physiology of chondrocytes from proliferation to differentiation 5, 6 . In fact, aged ERa null mice show an early closure of the epiphyseal growth plate in long bones 7 . ERa exerts its function by binding to the estrogen response elements (EREs) in the promoter region of the target genes, recruiting many cofactors to form a large multisubunit complex, which defines the transcription of the genes 8 . Glucocorticoid receptor-interacting protein 1 (GRIP1) is one of the p160 steroid receptor coactivator (SRC) gene family that interacts with nuclear receptors 9 . Interaction of GRIP1 with E 2 -bound ERa recruits histone acetyl-transferase and cAMP response elementbinding (CREB) binding protein (CBP)/p300, and leads to form a large coactivator complex. Through phosphorylation of the coactivator complex, some of the signaling cascades are known to promote target gene expressions. p38 mitogen-activated protein kinase (MAPK), a member of MAPK signaling pathway, is reported to stimulate the ERa-dependent ERE transcription by phosphorylation of S736 of GRIP1 in breast and endometrial carcinoma cells 10 .
A crosstalk between ERa and p38 MAPK enhances ERa-dependent tumor growth in MCF-7 cells 11 . In ATDC5 cells, a transcriptional crosstalk among Sma and mothers against decapentaplegic (MAD)-related protein 2 (Smad2), extracellular signal-regulated kinase 1/2 (ERK1/2), and p38 MAPK regulates aggrecan gene expression 12 . One of the signal transduction modulators in the transforming growth factor (TGF)-b signaling, p38 MAPK, plays an important role for proliferation of chondrocytes 13 . TGF-b rapidly activates p38 MAPK and its direct activator mitogen-activated protein kinase kinase (MKK) 6 in its transcriptional activation in mouse mammary gland cell 14 . However, it remains to be determined whether estrogen affects MKK6-p38 MAPK pathways in chondrocytic cells.
Type II collagen is a major extracellular matrix component of the articular cartilage and has crucial roles in cartilaginous homeostasis. Transcription of col2a1 is mainly controlled by sex-determining region Y (SRY)-type high mobility group box9 (Sox9) 15, 16 . Sox9 binds to the enhancer region of col2a1 gene, which is located in the first intron, and forms a large transcriptional complex with cofactors such as CBP/p300 17 . The transcriptional complex is believed to bend backward and make a contact with the general transcriptional machinery, especially RNA polymerase at a translation initiation site leading to chondrocyte-specific expression of col2a1
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. TGF-b1 controls the Sox9-mediated col2a1 transcription by Smad-dependent 19 and -independent pathways 20 . Both the TGF-b/Smad3 and TGF-b/MKK6/p38 MAPK pathways result in the formation of Sox9-containing transcriptional complex. In addition, Sox9 is a posttranscriptional target of the p38 MAPK pathway in chondrocytes. Indeed, p38 MAPK is involved in both superinduction of Sox9 by cycloheximide and stabilization of Sox9 mRNA 21 .
Here, we verified a hypothesis that the postmenopausal estrogen depletion accelerates cartilage degradation by examining the phenotypes of ERa null mice. We present evidence that estrogen increases col2a1 transcription through the TGFeMKK6 pathway in primary chondrocytes (PCs) and chondrogenic ATDC5 cells. Furthermore, we revealed the function of GRIP1 in ERa-dependent col2a1 expression and glycosaminoglycan (GAG) production in ATDC5 cells. The results obtained in this study manifest the role of estrogen in the maintenance of cartilage homeostasis.
Materials and methods

Plasmids
A DNA fragment containing 1 kb human col2a1 promoter or a col2a1-4 Â 48 bp enhancer and basal promoter (À164 to 37 bp) was generated by PCR using genomic DNA from HeLa cells. The fragments were cloned into pGL3-basic (Promega, Madison, WI). The constructs were verified by DNA sequencing. Human ERa and dominantnegative (DN) ERa plasmids were gifts from Dr. D.P. McDonnell
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. ERE-TATA-luc was from Dr. J. Yanagisawa 23 . MKK6CA was from Dr. T. Sudo 24 . Sox9 and p300 were gifts from Dr. H. Asahara 17 . GRIP1 and GRIP1-DAD1 (full-length GRIP1 without amino acids 1057e1109) plasmids were from Dr. M. Stallcup 
Histological stainings
Heterozygous ERa null mice in C57BL/6 background were purchased from Taconic (Hudson, NY). The animals were kept under pathogen-free conditions and cared for in accordance with the Laboratory Animal Care and Use Committee of School of Medicine Keio University. The dissected lumbar units of wild-type (WT) and ERa null female mice were fixed in 10% neutral buffered formalin. The samples were decalcified by 5% formic acid, paraffinembedded, and sectioned to 4 mm thickness. The decalcified sections were stained with alcian blue and type II collagen with rabbit anti-mouse polyclonal antibody (Millipore, Billerica, MA) as previously described 27 .
Cell culture and treatments
PCs of WT and ERa null mice were prepared from newborn and E18.5 embryos in pregnant heterozygous ERa null mice as described 28 . PCs were plated in 24-well dish at a density of 1 Â10 5 cells in 0.5 ml of Dulbecco's modified Eagle's medium (DMEM)/F12 and 10% fetal bovine serum (FBS). Next day, the medium was replaced by a fresh medium supplemented with 2% Charcoal/ Dextran treated FBS (HyClone, Waltham, MA), 10
À7 M E 2 and 10 ng/ ml TGF-b1. After 16 h, RNA was recovered from chondrocytes with RNAiso (Takara Bio, Shiga, Japan) for reverse transcription polymerase chain reaction (RT-PCR).
RT-PCR
Total RNA was used for the first strand cDNA synthesis with SuperScript II (Invitrogen, Carlsbad, CA). Real-time RT-PCR amplification was carried out using a SYBR Premix Ex Taq (Takara Bio) in a Light Cycler Quick System (Roche Diagnostics, Mannheim, Germany). Relative mRNA expression levels were obtained by normalization against 18S rRNA. The experiments were repeated at least three times to confirm the reproducibility. The primers for real-time RT-PCR used were: mouse 18S rRNA 5 0 -ATCAGATACCG TCGTAGTTCC-3 0 and 5 0 -TGCCCTTCCGTCAATTCC-3 0 ; mouse col2a1 
Luciferase reporter assay
ATDC5 cells were maintained in DMEM/F12 containing 5% FBS and antibiotics. Cells were plated at 7500 cells in a 48-well plate and transfected with a 50 ng luciferase reporter plasmid containing a human col2a1 promoter, which harbors a 4 Â 48 enhancer element, a col2a1 promoter without the enhancer element, or a three consensus EREs TATA luciferase reporter with Lipofectamine 2000, according to the protocol provided (Invitrogen). We also transfected 5-100 ng of a DN ERa expression vector 22 . One day after transfection, cells were incubated with 2% Charcoal/Dextran treated FBS for 4 h and were stimulated by 10 À7 M or 10 À9 M E 2 in the presence of For luciferase assays using ON-TARGET plus small interfering RNA (siRNA) (Dharmacon, Lafayette, CO), we adopted a different protocol. Twenty-four hours prior to transfection of the luciferase reporters, ATDC5 cells were seeded at a density of 1 transfection was repeated every 3 days. Culture media and cell lysates were harvested for GAG measurements at 14 and 21 days after plating. Cells were harvested with ice-cold saline solution containing 0.2% of Triton X-100 (Wako, Osaka, Japan). Cell lysates were centrifuged at 2 Â 10 3 g for 5 min, and the supernatant was used for determination of DNA content and sulfated GAG, as described previously 29, 30 .
Statistical analysis
Statistical analysis was performed by Student's t test. P values less than 0.05 were considered significant.
Results
Cartilaginous endplate impairment in ERa null mice
We compared the skeletal growth plate morphology of female ERa null mice with that of age matched female WT mice. There was no difference in the morphology of 4-month-old mice between the two genotypes. As reported 7 , the 15-month-old ERa null mice had a closure of the epiphyseal growth plate in the proximal tibia, while WT mice showed no sign of the growth plate closure [ Fig. 1(A) ]. We also found more prominent decrease in the thickness of the vertebral cartilaginous endplate in 15-month-old ERa null mice compared to WT. As shown in Fig. 1(B) , the number of alcian blue-positive chondrocytes decreased in the cartilaginous endplate of 15-month-old ERa null mice. The disorganized cartilage was replaced by bony tissues. Immunostaining of type II collagen revealed that the collagen-negative areas increased in the vertebral cartilaginous endplate of the ERa null mice [ Fig. 1(B) ]. These results suggested that the inactivation of the ERa gene caused impaired development of the mouse vertebral endplate cartilage in vivo.
Regulation of col2a1 expression in mouse PCs
Because in vivo results described above indicated the possible link between the signaling elicited by ERa and the col2a1 expression in chondrocytes, we examined the direct effect of E 2 on the col2a1 expression using mouse PCs by RT-PCR and quantitative real-time RT-PCR. PCs precultured with 2% FBS were stimulated with 10 À9 e10 À7 M E 2 for 16 h. E 2 increased the col2a1 message at all concentrations tested [ Fig. 2(A) ]. Real-time RT-PCR confirmed a significant increase in col2a1 message by E 2 [ Fig. 2(B) ]. To confirm Scale bar, 100 mm.
the involvement of ERa in the E 2 -dependent col2a1 upregulation, we determined the effect of E 2 on col2a1 expressions using PCs prepared from ERa null mice. Real-time RT-PCR revealed that the E 2 -dependent increase in the col2a1 expression observed in WT PCs disappeared in ERa null PCs [ Fig. 2(C) ]. Additionally, TGF-b1 stimulation further increased the E 2 -dependent col2a1 message in WT PCs. The results suggest that the upregulation of col2a1 expression by ERa-dependent E 2 signaling is mediated via TGF-b1 signaling in mouse PCs. Twenty-four hours after the second transfection, cell lysates were prepared for luciferase assay. *Significantly different from RLA without E 2 stimulation, P < 0.05. N ¼ 3.
Results were expressed as the ratio of the firefly activities to the Renilla activities. 
E 2 -dependent regulation of col2a1 transcription via TGF-b/P38MAPK signaling
Because the histological findings of ERa null mice accorded with the in vitro E 2 -dependent increase in col2a1 expression of the isolated mouse PCs, we examined the mechanism of E 2 -dependent col2a1 transcription using the luciferase reporter system in ATDC5 cells, a chondrogenic cell line. ATDC5 cells were transfected with the col2a1 luciferase reporter, which harbors a human col2a1 promoter and a 4 Â 48 bp enhancer [ Fig. 3(A) ]. E 2 at 10 À7 M increased the reporter activity by fourfold. This increase was completely blocked by 10 À7 M ICI182780, an E 2 antagonist. On the other hand, TGF-b1 at 10 ng/ml also increased the col2a1 reporter activity by fivefold. The increase was cancelled by 10 À5 M SB202190, a p38 MAPK inhibitor. A combination of E 2 and TGF-b1 increased the reporter activity by sixfold. Although the elevated transcriptional activity was partially blocked by ICI182780, SB202190 completely inhibited the activation of col2a1 reporter activity. Importantly, SB202190 attenuated both the E 2 -dependent and TGF-b1-dependent col2a1 reporter activity to the basal level. The E 2 and TGF-b1-induced activation of col2a1 transcription was inhibited by DN ERa in a dose-dependent manner, suggesting that E 2 -bound ERa participated in the p38 MAPK pathway to activate the col2a1 transcription in ATDC5 cells [ Fig. 3(B) ]. The luciferase reporter activity activated by cotransfection of Sox9, p300, and MKK6CA (constitutive-active MKK6) was also responsive to the E 2 stimulation [ Fig. 3(C) ]. The results accord with the notion that E 2 upregulated the Sox9-mediated activation of col2a1 transcription, which depends on the TGF-b1/p38 MAPK pathway. Future works are clearly needed to define the exact mechanism of interaction between the E 2 -mediated pathway and the TGF-b1/p38 MAPK pathway in the Sox9-mediated activation of col2a1 transcription before reaching this conclusion.
GRIP1 as a coactivator of ERE-dependent transcription in chondrocytes
To further dissect the mechanism of E 2 -mediated upregulation of col2a1 transcription, we elucidated the roles of GRIP1 on the ERE-specific gene regulation in chondrocytes. First, we investigated the effect of GRIP1 on the interaction of ERa and MKK6 using ERE-TATA-luc in ATDC5 cells. In the presence of E 2 , MKK6CA increased the reporter activity by threefold and a combination of MKK6CA and ERa increased the activity by sevenfold [ Fig. 4(A) ]. DN ERa completely cancelled the MKK6CA-induced reporter activity, probably indicating that the activation of luciferase activity by MKK6 required the endogenous ERa. Interestingly, GRIP1 significantly enhanced the activity induced by MKK6CA and ERa in the presence of E 2 . The GRIP1-induced increase in the ERE-luc activity was abolished by the cotransfection of GRIP1 siRNA. The GRIP1-dependent activation of the ERE reporter activity was also inhibited by the cotransfection of GRIP1 mutant, GRIP1-DAD1 in the presence of E 2 [ Fig. 4(B) ], underlining the specificity of GRIP1 in the estrogendependent transcription activity in ATDC5 cells. Finally, we examined the role of GRIP1 in the col2a1 transcription using the col2a1 luciferase reporter with a 1 kb human col2a1 promoter (À976 to 0) without the enhancer element in ATDC5 cells [ Fig. 4(C) ]. Although the reporter activity in the presence of E 2 was higher than that in the absence of E 2 , the increase was not significant. GRIP1, MKK6CA and ERa conferred the significant E 2 response on the reporter activity. The E 2 responsiveness was cancelled by the cotransfection of GRIP1 siRNA. These results supported the contention that GRIP1 acted as a coactivator in the col2a1 transcriptional machinery in ATDC5 cells and that 1 kb upstream sequence of col2a1 gene contained the putative ERE motif. We next confirmed the effect of GRIP1 on the endogenous extracellular matrix production by ATDC5 cells using GRIP1 siRNA.
Transient transfection of GRIP1 siRNA substantially decreased the GRIP1 expression in ATDC5 cells with concomitant decrease in the col2a1 message [ Fig. 5(A) ]. The effect of GRIP1 siRNA was also tested by the quantification of GAG in the cell matrix and supernatant of ATDC5 cells [ Fig. 5(B) ]. Transfection of GRIP1 siRNA significantly decreased the ratio of GAG/DNA at 21 days of culture, but not at 14 days. These results clearly showed that GRIP1 acted as a positive regulator not only for the col2a1 transcription but also for the GAG production in ATDC5 cells.
We examined if ERa and GRIP1 colocalize in the nucleus using confocal microscopy. Nuclear localization of ERa detected by indirect immunofluorescence was compared with that of the transiently expressed EGFP-GRIP1 in ATDC5 cells [ Fig. 5(C) ]. GRIP1 expression in ATDC5 cells showed various morphologies from diffuse nucleoplasmic staining with the low intensity to discrete intranuclear foci with high intensity as described in HeLa cells 26 .
ERa antibody produced numerous granular staining patterns. A few of the ERa-positive granules overlapped with some of the GRIP1-positive granules which showed the intermediate intensity.
The overlapped granules might represent the active transcriptional complex that include both ERa and GRIP1
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.
Discussion
The aim of the present study is to resolve the relationship between estrogen and cartilage metabolism. It has been reported that 6-month-old ERa null female mice show no sign of cartilage damage in the knee joints 32 . Consistent with this, we could not observe an impaired development of the cartilaginous endplate in 4-month-old ERa null female mice (data not shown). In contrast, ERa null female mice at 15-month-old showed an obvious impaired development of the cartilaginous endplate with a reduced number of chondrocytes [ Fig. 1(B) ]. Similar phenotypes were also observed in ovariectomized rats at 3 and 7 months after surgery (Supplementary data). Because the depletion of estrogen and functional loss of ERa exhibited the similar phenotypes, it is reasonable to speculate that estrogen has a positive role on the homeostasis of the cartilaginous vertebral endplate in the aged animals. Especially, the function of ERa seemed to be critical for the maintenance of the cartilage matrix. This notion was supported by in vitro experimental results using the ERa null PC [ Fig. 2(C) ] and the col2a1 reporter assay [ Fig. 3(B) ].
Here we showed that the E 2 induced col2a1 expression is mediated by ERa in PCs (Fig. 2) . The E 2 -dependent activation Results obtained from the reporter assays and various inhibitors indicated that E 2 transmits its signal through p38 MAPK in the col2a1 transcription in ATDC5 cells [ Fig. 3(A) ]. It has already been well established that the Sox9-dependent col2a1 enhancer activity is regulated through MKK6 and p38 MAPK in PCs 20 . Thus, E 2 appears to be one of the upstream signals of the col2a1 transcriptional regulation through MKK6 and p38 MAPK. Because TGF-b1 causes p38 MAPK activation without Smad in mouse mammary epithelial cells 14 , we speculate that the Smad-independent TGF-b signaling elicits p38 MAPK activation in the E 2 induced the col2a1 expression (see Fig. 6 for details). Future studies are needed to clarify the complexity of such crosstalks. Because GRIP1 is widely recognized as a transcriptional coactivator of the nuclear receptors including ERa, we examined the role of GRIP1 in the E 2 induced col2a1 expression in ATDC5 cells. As expected, the experiments using GRIP1 siRNA clearly showed the involvement of GRIP1 in the E 2 induced col2a1 expression [ Fig. 5(A) ]. Moreover, GRIP1 siRNA inhibited the production of sulfated GAGs in ATDC5 cells, implying a wider range of estrogendependent transcriptional controls of extracellular matrix proteins in chondrocytes.
Taken together, the results obtained in this study accord with a notion that GRIP1-bound ERa induces the col2a1 gene expression through an interaction with the TGF/MKK6 pathway. This study sheds a light on the apparent controversies about the relationship between the role of estrogen and cartilage degeneration in postmenopausal women. A novel functional cooperation between GRIP1/ERa and TGF/MKK6 signaling, shown in our study, may therefore lead to a better understanding of transcriptional networks and the development of a novel therapeutics approach against postmenopausal cartilage degeneration in the future.
